01 Oct YProtech secures expansion capital following impressive growth
- Acceleris Capital arranged a funding package of £0.4m via a combination of debt and new equity investment.
- The funds are to be used to grow the company at Alderley Park and invest in additional commercial resource to drive further growth.
- The Company has grown significantly and has been consistently profitable throughout 2018 following break-even being reached in January 2018.
YProtech Ltd is a specialist High Value Chemistry Services Company formed in 2011 aimed primarily at the Life Sciences sector. Based at Alderley Science Park, Cheshire, the core of the Company’s business relates to the provision of chemistry technical services to companies in the pharmaceutical, biotechnology and applied chemistry sectors. Offering core services including Medicinal Chemistry, Contract Research Scale up synthesis and specialist High Potency Synthesis and associated products YProtech has established a strong customer base and platform for expansion.
Since the previous fundraising in October 2016, the Company has grown its revenues impressively and reached profitability in early 2018. YProtech now boasts a diverse customer base from the UK, Europe and the US and includes both listed and private companies, large corporates, universities and other research institutions.
The funds will be used to provide additional growth capital to further exploit the niche service offering in YProtech’s high-potency facilities as well as to capitalise further on the provision of medicinal chemistry expertise and chemistry services.